Pooled Complement Human Serum Reference 3-31-14


Written by Kelsey on June 11, 2015. Posted in References

Innovative Research's Pooled Complement Human Serum was recently used in the following study:

Longitudinally extensive NMO spinal cord pathology produced by passive transfer of NMO-IgG in mice lacking complement inhibitor CD59

H Zhang, AS Verkman - Journal of Autoimmunity, 2014
Human complement (Innovative Research, Novi, MI) and NMO-IgG were then added in Hank's buffer, and cells were incubated at 28 C for 2 h. Cytotoxicity was measured by the Alamar Blue assay (Invitrogen). 2.5. NMO-IgG binding.

© 2019 Innovative Research. All Rights Reserved.